Preparation method of antiviral glycyrrhizic acid powder

By combining modified adsorption resin and licorice carbon dots, the problems of low glycyrrhizic acid purity and secondary pollution were solved, realizing the extraction and selective delivery of high-purity glycyrrhizic acid and expanding its application in the high-end market.

CN119015230APending Publication Date: 2024-11-26SHA CHE FU YUAN LICORICE PROD CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411123280.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The purity of existing glycyrrhizic acid products is not high, traditional extraction and separation processes are complex, and commonly used resins may cause secondary pollution to the separated products, which limits its application in the high-end market.

Method used

A method combining modified adsorption resin and licorice carbon dots was adopted. The resin was prepared by modifying the crosslinking agent to enhance the adsorption capacity, and glycyrrhizic acid was modified onto the licorice carbon dots to reduce side effects by utilizing the selective delivery of carbon dots.

Benefits of technology

This improved the extraction purity and utilization rate of glycyrrhizic acid, reduced the occurrence of side effects, and expanded the application of glycyrrhizic acid products in the high-end market.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the field of separation and purification, and particularly discloses a preparation method of antiviral glycyrrhizic acid powder, which effectively improves the extraction purity of glycyrrhizic acid, modifies the glycyrrhizic acid to plant-based carbon dots, and reduces the distribution of glycyrrhizic acid in other tissues and organs of a human body through selective delivery of the carbon dots while playing an antiviral role. And side effects are reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of separation and purification, and particularly relates to a method for preparing antiviral glycyrrhizic acid powder. Background Art

[0002] Current viral diseases pose a serious threat to global public health security. Glycyrrhizic acid, a natural medicine extracted from the roots and rhizomes of Licorice plants, is widely believed to have potential antiviral activity. It has shown antiviral effects against hepatitis viruses and herpes viruses in some studies, and has also shown good potential in fighting the new coronavirus.

[0003] The specific antiviral mechanism of glycyrrhizic acid involves multiple levels, including direct inhibition of viral replication, interference with the interaction between virus and host cells, and enhancement of the host's immune response. For example, glycyrrhizic acid can inhibit HIV replication by inducing the production of β-chemokines, reducing the fluidity of cell membranes to reduce cell fusion, thereby inhibiting the reproduction and spread of HIV between cells; glycyrrhizic acid can significantly inhibit the production of CC chemokine ligand 2 and interleukin-10, effectively inhibiting R5HIV from entering cells.

[0004] Existing glycyrrhizic acid products usually have more impurities and the purity is not high enough. The traditional extraction and separation process is also relatively complicated. These problems limit the application and development of glycyrrhizic acid products in the high-end market. Patent CN104262448B provides a method for extracting glycyrrhizic acid from licorice. The extraction method has simple operation steps and low instrument requirements, but there is still room for improvement in yield and purity. Patent CN114634534B provides a method for separating glycyrrhizic acid monoammonium salt and liquiritin from glycyrrhizic acid monoammonium salt mother liquor. By reasonably controlling the type of large-aperture resin and the type of eluent in the elution process and the gradient elution step, the separation efficiency of liquiritin is significantly improved, and the yield and purity of liquiritin are significantly improved. However, the resin in this method is mostly based on petroleum extract styrene as the skeleton, which is easy to cause secondary pollution to the separated product during the purification process, thereby affecting the efficacy of the natural product. Summary of the invention

[0005] In order to overcome the deficiencies of the above-mentioned prior art, the present invention provides a method for preparing antiviral glycyrrhizic acid powder, which effectively improves the extraction purity of glycyrrhizic acid, and modifies high-purity glycyrrhizic acid onto plant-based carbon dots, which not only plays an antiviral role but also reduces the distribution of glycyrrhizic acid in other tissues and organs of the human body through the selective delivery of carbon dots, thereby reducing the occurrence of side effects.

[0006] To achieve the above object, the technical solution adopted in the present invention is:

[0007] The present invention provides a method for preparing antiviral glycyrrhizic acid powder, comprising the following steps:

[0008] (1) Grinding the dried licorice to a constant weight, adding a sodium bicarbonate-ethanol aqueous solution, stirring at 40-60° C. for 60-120 min, then ultrasonicating at 80-90° C. at 160-200 W for 120-180 min, filtering, collecting the filtrate, repeating the above steps for 2-3 times for the filter residue, combining all the filtrates, and concentrating the filtrate to 1 / 5-1 / 4 of the original volume to obtain a glycyrrhizic acid concentrate;

[0009] (2) adsorbing the glycyrrhizic acid concentrate in step (1) with a modified adsorption resin for 10-14 hours, then eluting, collecting the eluate, concentrating and drying to obtain glycyrrhizic acid;

[0010] (3) dissolving glycyrrhiza polysaccharide in deionized water, adding ethylenediamine, stirring ultrasonically for 10-20 min, hydrothermally reacting at 180-220° C. for 4-6 h, cooling to room temperature, centrifuging, and dialyzing the supernatant in deionized water for 22-26 h. The dialyzate was replaced every 4-5 h. After the dialysis was completed, the supernatant was freeze-dried to obtain glycyrrhiza carbon dots;

[0011] (4) Dissolve the glycyrrhizic acid in step (2) in a PBS buffer solution with a pH of 7-8, then add an aqueous solution containing EDC and NHS, stir for 10-14 hours, add the licorice carbon dots in step (3), stir for 20-28 hours, dialyze for 20-28 hours, and freeze-dry to obtain the antiviral glycyrrhizic acid powder.

[0012] In some embodiments, the particle size of the licorice ground and sieved in step (1) is 250-325 mesh.

[0013] In some embodiments, the mass ratio of glycyrrhizin polysaccharide to ethylenediamine in step (3) is 1:(1.3-1.8).

[0014] In some embodiments, the mass ratio of glycyrrhizic acid to glycyrrhizic carbon dots in step (4) is 1:(1.5-2.5).

[0015] Glycyrrhizic acid is the main bioactive ingredient in the traditional Chinese medicine licorice. It can effectively inhibit the growth and replication of various viruses by stabilizing cell membranes and regulating the immune system. It has specific effects on the expression and activity of specific virus-related enzymes. However, studies have pointed out that large-scale intake of licorice may lead to excessive mineral corticosteroids, sodium retention, potassium loss, edema, increased blood pressure, and a decrease in the renin-angiotensin-aldosterone system. These side effects indicate that attention should be paid to dosage control when using glycyrrhizic acid to avoid potential adverse reactions.

[0016] The present invention prepares licorice polysaccharide into licorice carbon dots. The raw material of the carbon dots is natural and has good biocompatibility. The loaded drugs can be specifically delivered to the targeted sites. The present invention utilizes the amide reaction between the active -NH2 on the surface of the carbon dots and -COOH on the glycyrrhizic acid and the hydrogen bonding force between the glycyrrhizic acid and the licorice carbon dots to modify the glycyrrhizic acid onto the licorice carbon dots. The complex has low cytotoxicity and reduces the distribution of glycyrrhizic acid in other tissues and organs of the human body through the selective delivery of the carbon dots, thereby reducing the generation of side effects.

[0017] In some embodiments, the preparation steps of the modified adsorption resin in step (2) are as follows:

[0018] A1, mixing a modified crosslinking agent, hydroxyethyl methacrylate, azobisisobutyronitrile, isooctane and ethyl acetate to obtain a solution 1;

[0019] A2. Sodium lauryl sulfate, polyvinyl alcohol and deionized water are stirred at 50-60° C. and 100-300 rpm to obtain solution 2, and solution 1 in step A1 is added, and the temperature is raised to 75-85° C. and kept warm for 1-3 hours, and the temperature is further raised to 90-110° C. and kept warm for 1-3 hours. The obtained product is washed with water for the first time, sieved, extracted, washed with water for the second time, and dried to obtain the modified adsorption resin.

[0020] In some embodiments, the mass ratio of the modified cross-linking agent to hydroxyethyl methacrylate in step A1 is 1:(5.84-6.79).

[0021] In some embodiments, the mass ratio of the modified cross-linking agent in step A1 to the polyvinyl alcohol in step A2 is 1:(0.0055-0.0080).

[0022] Adsorption resins are inexpensive, easy to operate, and have good adsorption effects. They have been widely used in the separation and purification of active ingredients in natural products. However, the synthetic raw materials of commercial resins mostly use compounds extracted from non-renewable petroleum resources as cross-linking agents. If they are not cleaned up during the pretreatment process, they will cause secondary pollution to the natural products, thereby affecting the efficacy of the natural products.

[0023] The present invention develops a clean, non-toxic, green and environmentally friendly adsorption resin. The resin contains a rich and fluffy pore structure, which strengthens the adsorption force within the adsorption resin and the binding ability between glycyrrhizic acid and the macroporous adsorption resin, thereby improving the purity of the desorbed glycyrrhizic acid, strengthening the binding between high-purity glycyrrhizic acid and licorice carbon dots, improving the utilization rate, and reducing the excess amount of low-purity glycyrrhizic acid.

[0024] In some embodiments, the preparation steps of the modified cross-linking agent are as follows:

[0025] S1. Glycinamide hydrochloride, deionized water and potassium carbonate solution were mixed and stirred until no solid was present, then ether was added, the temperature was adjusted to -2 to 3°C after stirring evenly, acryloyl chloride-ether solution was added dropwise, stirred for 4 to 5 hours, extracted, pH was adjusted to neutral, freeze-dried, recrystallized and filtered to obtain product 1;

[0026] S2, mixing the product 1 in step S1 with a methanol-water solution and stirring until no solid is present, adding diethanolamine, stirring at 35-45° C. for 20-30 h, washing, filtering, and vacuum drying to obtain a product 2;

[0027] S3, stirring the product 2 in step S2 and rosin at 80-85° C., then dropping sulfuric acid, and refluxing for 1-4 hours, extracting and recrystallizing to obtain the modified crosslinking agent.

[0028] In some embodiments, the mass ratio of product 1 to diethanolamine in step S2 is 1:(0.65-0.70).

[0029] In some embodiments, the mass ratio of product 2 to rosin in step S3 is 1:(2.8-3.3).

[0030] The invention synthesizes a cross-linking agent containing rosin groups. The cross-linking agent firstly brings excellent rigidity to the resin, so that the formed resin is not easy to collapse when loaded into a column, and ensures that the surface structure of the resin can be kept intact when the resin is regenerated and used multiple times; secondly, the cross-linking agent uses biomass materials as raw materials, thereby reducing the use of non-renewable petroleum resources; thirdly, the resin obtained by polymerization of the cross-linking agent has a more uniform network structure, reducing the formation of uneven micro-regions, so that the resin can more conveniently absorb and desorb glycyrrhizic acid.

[0031] Compared with the prior art, the present invention has the following beneficial effects:

[0032] 1. The present invention provides a process for extracting high-purity glycyrrhizic acid and modifying it onto licorice carbon dots, which not only plays an antiviral role but also reduces the distribution of glycyrrhizic acid in other tissues and organs of the human body through the selective delivery of carbon dots, thereby reducing the occurrence of side effects.

[0033] 2. The adsorption resin used in the present invention is clean, non-toxic, green and environmentally friendly. It not only enhances the binding ability between glycyrrhizic acid and the macroporous adsorption resin, thereby improving the purity of the desorbed glycyrrhizic acid, but also strengthens the binding between high-purity glycyrrhizic acid and licorice carbon dots, thereby improving the utilization rate.

[0034] 3. The present invention reduces the use of non-renewable petroleum resources by synthesizing biomass-based cross-linking agents, and brings excellent rigidity and a more uniform network structure to the resin. The former makes the formed resin less likely to collapse when loaded into a column, ensuring that the integrity of the resin surface structure can be maintained when the resin is regenerated and used multiple times; the latter makes it easier for the resin to absorb and desorb glycyrrhizic acid. DETAILED DESCRIPTION

[0035] The present invention will be described below in conjunction with specific embodiments. It should be noted that the following embodiments are examples of the present invention and are only used to illustrate the present invention, but not to limit the present invention. Other combinations and various modifications within the concept of the present invention may be performed without departing from the spirit or scope of the present invention.

[0036] In order to facilitate those skilled in the art to implement the present invention, some raw material manufacturers of the embodiments and comparative examples are described as follows:

[0037] Rosin was purchased from Guangxi Wuzhou Richeng Forest Products Chemical Co., Ltd., model: rosin-WW grade;

[0038] Licorice polysaccharide was purchased from Ningxia Blue Peptide Bioengineering Co., Ltd.;

[0039] Polyvinyl alcohol was purchased from Anhui Wanwei High-tech Materials Co., Ltd., model 04-99 (L).

[0040] Preparation Example 1

[0041] The preparation steps of modified crosslinking agent-A are as follows:

[0042] S1, 63g of glycine amide hydrochloride, 60mL of deionized water and 336mL of 2mol / L potassium carbonate solution were mixed and stirred until there was no solid, then 180mL of ether was added, the temperature was adjusted to 0°C after stirring evenly, a solution formed by 240mL of ether and 57g of acryloyl chloride was added dropwise, and the mixture was stirred for 5h, extracted with ether 3 times, the pH of the extract was adjusted to neutral with 2mol / L sodium hydroxide solution, and 2500mL of a 4:1 ethanol / methanol mixed solvent was added after freeze drying, and the residue was removed by suction after stirring for 3h, and the solution was evaporated until turbidity appeared, and then placed at -5°C for recrystallization, filtered, and the product 1 was obtained;

[0043] S2, 50 g of product 1 was mixed with 90 mL of methanol and 40 mL of deionized water and stirred until no solid was present, 34.1 g of diethanolamine was added, and the mixture was stirred at 40° C. for 26 h, washed with acetone, filtered, and dried in vacuo to obtain product 2;

[0044] S3, 219g of product 2 and 665g of rosin were stirred evenly at 83°C, and then 56mL of 60wt% sulfuric acid was dropped into the mixture. After reflux reaction for 3h, the modified crosslinking agent-A was obtained by extraction with ethyl acetate and recrystallization with methanol.

[0045] Preparation Example 2

[0046] The preparation steps of modified crosslinking agent-B are as follows:

[0047] The difference between this preparation example and preparation example 1 is that 31 g of diethanolamine is used in step S2.

[0048] Preparation Example 3

[0049] The preparation steps of modified crosslinker-C are as follows:

[0050] The difference between this preparation example and preparation example 1 is that 36 g of diethanolamine is used in step S2.

[0051] Preparation Example 5

[0052] The preparation steps of modified crosslinker-D are as follows:

[0053] The difference between this preparation example and preparation example 1 is that 604 g of rosin is used in step S3.

[0054] Preparation Example 6

[0055] The preparation steps of modified crosslinker-E are as follows:

[0056] The difference between this preparation example and preparation example 1 is that 755 g of rosin is used in step S3.

[0057] Preparation Example 7

[0058] The preparation steps of modified adsorption resin-A are as follows:

[0059] A1, 25 g of modified crosslinking agent-A, 156.25 g of hydroxyethyl methacrylate, 0.33 g of azobisisobutyronitrile, 13.1 g of isooctane and 100 g of ethyl acetate were mixed to obtain solution 1;

[0060] A2. At 55°C, 0.17 g of sodium dodecyl sulfate, 0.17 g of polyvinyl alcohol and 668 g of deionized water were stirred at a speed of 150 rpm to obtain solution 2, and the solution 1 in step A1 was added, the temperature was raised to 80°C and kept warm for 2 h, and the temperature was further raised to 100°C and kept warm for 2 h. The obtained product was washed with water for the first time, passed through a 40-mesh sieve, extracted in anhydrous ethanol for 4 h, washed with water for the second time, and dried at 50°C to constant weight to obtain modified adsorption resin-A.

[0061] Preparation Example 8

[0062] The preparation steps of modified adsorption resin-B are as follows:

[0063] The difference between this preparation example and preparation example 7 is that in step A1, the modified crosslinking agent-A is replaced by an equal amount of modified crosslinking agent-B.

[0064] Preparation Example 9

[0065] The preparation steps of modified adsorption resin-C are as follows:

[0066] The difference between this preparation example and preparation example 7 is that in step A1, the modified crosslinking agent-A is replaced by an equal amount of modified crosslinking agent-C.

[0067] Preparation Example 10

[0068] The preparation steps of modified adsorption resin-D are as follows:

[0069] The difference between this preparation example and preparation example 7 is that in step A1, the modified crosslinking agent-A is replaced by an equal amount of modified crosslinking agent-D.

[0070] Preparation Example 11

[0071] The preparation steps of modified adsorption resin-E are as follows:

[0072] The difference between this preparation example and preparation example 7 is that in step A1, the modified crosslinking agent-A is replaced by an equal amount of modified crosslinking agent-E.

[0073] Example 1

[0074] A method for preparing antiviral glycyrrhizic acid powder comprises the following steps:

[0075] (1) 50 g of licorice dried to constant weight was crushed through a 270-mesh sieve, 500 mL of a 50% ethanol aqueous solution containing 0.5 g of sodium bicarbonate was added, and the mixture was stirred at 50° C. for 90 min, and then ultrasonicated at 85° C. for 150 min at 180 W, filtered, and the filtrate was collected. The above steps were repeated for 3 times on the residue, and all the filtrates were combined and concentrated to 1 / 5 of the original volume to obtain a glycyrrhizic acid concentrate;

[0076] (2) adsorbing the glycyrrhizic acid concentrate in step (1) with 10 times the weight of modified adsorption resin-A for 12 hours, then eluting with 50v% ethanol aqueous solution, collecting the eluate, concentrating and drying at 50°C to obtain glycyrrhizic acid;

[0077] (3) 5 g of glycyrrhiza polysaccharide was dissolved in 300 mL of deionized water, 7.5 g of ethylenediamine was added, and the mixture was subjected to ultrasonic stirring for 15 min, followed by hydrothermal reaction at 200 °C for 5 h, cooled to room temperature, and centrifuged at 10,000 rpm for 10 min to obtain the supernatant. The supernatant was dialyzed in deionized water for 24 h using a dialysis bag with a molecular weight cutoff of 1,000 Da. The dialysate was replaced every 4 h, and freeze-dried after the dialysis to obtain licorice carbon dots.

[0078] (4) Dissolve 0.5 g of glycyrrhizic acid in step (2) in 400 mL of PBS buffer with a pH of 7.4, then add 200 mL of an aqueous solution containing 1.3 g of EDC and 0.78 g of NHS, stir for 12 h, add 1 g of the licorice carbon dots in step (3), stir for 24 h, dialyze in deionized water for 24 h using a dialysis bag with a molecular weight cutoff of 1000 Da, and freeze-dry to obtain antiviral glycyrrhizic acid powder.

[0079] Example 2

[0080] A method for preparing antiviral glycyrrhizic acid powder comprises the following steps:

[0081] (1) 50 g of licorice dried to constant weight was crushed and passed through a 325 mesh sieve, 500 mL of a 50% ethanol aqueous solution containing 0.5 g of sodium bicarbonate was added, and the mixture was stirred at 40° C. for 120 min, and then ultrasonicated at 80° C. for 180 min at 200 W, filtered, and the filtrate was collected. The above steps were repeated twice for the residue, and all the filtrates were combined and concentrated to 1 / 5 of the original volume to obtain a glycyrrhizic acid concentrate;

[0082] (2) adsorbing the glycyrrhizic acid concentrate in step (1) with 10 times the weight of modified adsorption resin-A for 10 hours, then eluting with 50v% ethanol aqueous solution, collecting the eluate, concentrating and drying at 50°C to obtain glycyrrhizic acid;

[0083] (3) 5 g of licorice polysaccharide was dissolved in 300 mL of deionized water, 6 g of ethylenediamine was added, and the mixture was subjected to ultrasonic stirring for 10 min, and then hydrothermally reacted at 180 °C for 6 h. The mixture was cooled to room temperature, centrifuged at 10,000 rpm for 10 min, and the supernatant was dialyzed in deionized water for 22 h using a dialysis bag with a molecular weight cutoff of 1,000 Da. The dialysate was replaced every 5 h, and freeze-dried after the dialysis to obtain licorice carbon dots.

[0084] (4) Dissolve 0.5 g of glycyrrhizic acid in step (2) in 400 mL of PBS buffer with a pH of 7.0, then add 200 mL of an aqueous solution containing 1.3 g of EDC and 0.78 g of NHS, stir for 10 h, add 0.65 g of the licorice carbon dots in step (3), react for 20 h, dialyze in deionized water for 20 h using a dialysis bag with a molecular weight cutoff of 1000 Da, and freeze-dry to obtain antiviral glycyrrhizic acid powder.

[0085] Example 3

[0086] (1) 50 g of licorice dried to constant weight was crushed through a 250-mesh sieve, 500 mL of a 50% ethanol aqueous solution containing 0.5 g of sodium bicarbonate was added, and the mixture was stirred at 60° C. for 60 min, and then ultrasonicated at 160 W for 120 min at 90° C., filtered, and the filtrate was collected. The above steps were repeated for 3 times on the residue, and all the filtrates were combined and concentrated to 1 / 4 of the original volume to obtain a glycyrrhizic acid concentrate;

[0087] (2) adsorbing the glycyrrhizic acid concentrate in step (1) with 10 times the weight of modified adsorption resin-A for 14 hours, then eluting with 50v% ethanol aqueous solution, collecting the eluate, concentrating and drying at 50°C to obtain glycyrrhizic acid;

[0088] (3) 5 g of glycyrrhiza polysaccharide was dissolved in 300 mL of deionized water, 10 g of ethylenediamine was added, and the mixture was subjected to ultrasonic stirring for 20 min, and then hydrothermally reacted at 220 °C for 4 h. The mixture was cooled to room temperature, centrifuged at 10,000 rpm for 10 min, and the supernatant was dialyzed in deionized water for 24 h using a dialysis bag with a molecular weight cutoff of 1,000 Da. The dialysate was replaced every 4 h, and freeze-dried after the dialysis to obtain glycyrrhiza carbon dots.

[0089] (4) Dissolve 0.5 g of glycyrrhizic acid in step (2) in 400 mL of PBS buffer with a pH of 8.0, then add 200 mL of an aqueous solution containing 1.3 g of EDC and 0.78 g of NHS, stir for 14 h, add 1.4 g of the licorice carbon dots in step (3), stir for 28 h, dialyze in deionized water for 24 h using a dialysis bag with a molecular weight cutoff of 1000 Da, and freeze-dry to obtain antiviral glycyrrhizic acid powder.

[0090] Example 4

[0091] This embodiment provides a method for preparing an antiviral glycyrrhizic acid powder. The specific implementation method is the same as that of Example 1, except that in step (2), the modified adsorption resin-A is replaced by an equal amount of modified adsorption resin-B.

[0092] Example 5

[0093] This embodiment provides a method for preparing an antiviral glycyrrhizic acid powder. The specific implementation method is the same as that of Example 1, except that: in step (2), the modified adsorption resin-A is replaced by an equal amount of modified adsorption resin-C.

[0094] Example 6

[0095] This embodiment provides a method for preparing an antiviral glycyrrhizic acid powder. The specific implementation method is the same as that of Example 1, except that: in step (2), the modified adsorption resin-A is replaced by an equal amount of modified adsorption resin-D.

[0096] Example 7

[0097] This embodiment provides a method for preparing an antiviral glycyrrhizic acid powder. The specific implementation method is the same as that of Example 1, except that: in step (2), the modified adsorption resin-A is replaced by an equal amount of modified adsorption resin-E.

[0098] Comparative Example 1

[0099] This embodiment provides a method for preparing an antiviral glycyrrhizic acid powder. The specific implementation method is the same as that of Example 1, except that: in step (2), the modified adsorption resin-A is replaced by an equal amount of adsorption resin ADS-7 commonly used in the art.

[0100] Performance Test:

[0101] Glycyrrhizic acid purity test

[0102] The purity of the glycyrrhizic acid obtained in step (2) of each embodiment and comparative example was determined according to the HPLC method specified in the 2010 edition of the Pharmacopoeia. The glycyrrhizic acid was prepared into a solution with a concentration of 0.21 mg / mL. The chromatographic conditions were as follows: Agilent ZORBAX SB-C18 column (4.6 mm×150 mm, 5 um); mobile phase: acetonitrile (B)-0.05% phosphoric acid (A) gradient elution; flow rate: 1 mL·min -1 ; Detection wavelength 237nm; column temperature 25℃; injection volume 20uL.

[0103] The results are shown in Table 1.

[0104] Table 1

[0105] Glycyrrhizic acid purity % Example 1 95.2 Example 2 94.9 Example 3 94.8 Example 4 94.1 Example 5 93.8 Example 6 94.3 Example 7 94.0 Comparative Example 1 93.5

[0106] As shown in Table 1, the purity of glycyrrhizic acid in Examples 1-3 is higher than that of glycyrrhizic acid purchased from the China Institute for the Control of Pharmaceutical and Biological Products (batch number 110731-201116, purity 93.1%). Compared with glycyrrhizic acid of ordinary purity, the high-purity glycyrrhizic acid is more conducive to stabilizing cell membranes and immunomodulation, and can avoid excessive use of glycyrrhizic acid while achieving drug efficacy, reducing the generation of side effects, and expanding the application and development of glycyrrhizic acid products in the high-end market. As shown in Example 1, Examples 4-7 and Comparative Example 1, the self-made adsorption resin of the present invention helps to improve the purity of glycyrrhizic acid, which may be due to the fact that the resin has a more uniform network structure, reducing the formation of uneven micro-regions, thereby making it easier for the resin to absorb and desorb glycyrrhizic acid.

[0107] The embodiments described above do not impose any form of limitation on the present invention. Although the present invention has been disclosed as a preferred embodiment as above, it is not intended to limit the present invention. Any technician familiar with the profession can make some changes or modifications to equivalent embodiments of equivalent changes using the technical contents disclosed above without departing from the scope of the technical solution of the present invention. However, any simple modification, equivalent change and modification made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention still falls within the scope of the technical solution of the present invention.

Claims

1. A method for preparing antiviral glycyrrhizic acid powder, characterized in that: The following steps are involved: (1) Grinding and sieving the dried licorice to a constant weight, adding a sodium bicarbonate-ethanol aqueous solution, stirring at 40-60° C. for 60-120 min, and then ultrasonicating at 80-90° C. at 160-200 W for 120-180 min, filtering, collecting the filtrate, repeating the above steps for 2-3 times for the filter residue, combining all the filtrates, and concentrating the filtrate to 1 / 5-1 / 4 of the original volume to obtain a glycyrrhizic acid concentrate; (2) adsorbing the glycyrrhizic acid concentrate in step (1) with a modified adsorption resin for 10-14 hours, then eluting, collecting the eluate, concentrating and drying to obtain glycyrrhizic acid; (3) dissolving glycyrrhiza polysaccharide in deionized water, adding ethylenediamine, stirring ultrasonically for 10-20 min, hydrothermally reacting at 180-220° C. for 4-6 h, cooling to room temperature, centrifuging, and dialyzing the supernatant in deionized water for 22-26 h. The dialyzate was replaced every 4-5 h. After the dialysis was completed, the supernatant was freeze-dried to obtain glycyrrhiza carbon dots; (4) Dissolve the glycyrrhizic acid in step (2) in a PBS buffer solution with a pH of 7-8, then add an aqueous solution containing EDC and NHS, stir for 10-14 hours, add the licorice carbon dots in step (3), stir for 20-28 hours, dialyze for 20-28 hours, and freeze-dry to obtain the antiviral glycyrrhizic acid powder.

2. The method for preparing the antiviral glycyrrhizic acid powder according to claim 1, characterized in that: In the step (1), the particle size of the licorice powder after pulverization and screening is 250-325 meshes.

3. The method for preparing the antiviral glycyrrhizic acid powder according to claim 1, characterized in that: In the step (3), the mass ratio of glycyrrhizin polysaccharide to ethylenediamine is 1:(1.3-1.8).

4. The method for preparing the antiviral glycyrrhizic acid powder according to claim 1, characterized in that: In the step (4), the mass ratio of glycyrrhizic acid to glycyrrhizic carbon dots is 1:(1.5-2.5).

5. The method for preparing the antiviral glycyrrhizic acid powder according to claim 1, characterized in that: The preparation steps of the modified adsorption resin in step (2) are as follows: A1, mixing a modified crosslinking agent, hydroxyethyl methacrylate, azobisisobutyronitrile, isooctane and ethyl acetate to obtain a solution 1; A2. Sodium lauryl sulfate, polyvinyl alcohol and deionized water are stirred at 50-60° C. and 100-300 rpm to obtain solution 2, and solution 1 in step A1 is added, and the temperature is raised to 75-85° C. and kept warm for 1-3 hours, and the temperature is further raised to 90-110° C. and kept warm for 1-3 hours. The obtained product is washed with water for the first time, sieved, extracted, washed with water for the second time, and dried to obtain the modified adsorption resin.

6. The method for preparing the antiviral glycyrrhizic acid powder according to claim 5, characterized in that: In the step A1, the mass ratio of the modified crosslinking agent to hydroxyethyl methacrylate is 1:(5.84-6.79).

7. The method for preparing the antiviral glycyrrhizic acid powder according to claim 5, characterized in that: The mass ratio of the modified cross-linking agent in step A1 to the polyvinyl alcohol in step A2 is 1:(0.0055-0.0080).

8. The method for preparing the antiviral glycyrrhizic acid powder according to claim 5, characterized in that: The preparation steps of the modified cross-linking agent are as follows: S1. Glycinamide hydrochloride, deionized water and potassium carbonate solution were mixed and stirred until no solid was present, then ether was added, the temperature was adjusted to -2 to 3°C after stirring evenly, acryloyl chloride-ether solution was added dropwise, stirred for 4 to 5 hours, extracted, pH was adjusted to neutral, freeze-dried, recrystallized and filtered to obtain product 1; S2, mixing the product 1 in step S1 with a methanol-water solution and stirring until no solid is present, adding diethanolamine, stirring at 35-45° C. for 20-30 h, washing, filtering, and vacuum drying to obtain a product 2; S3, stirring the product 2 in step S2 and rosin at 80-85° C., then dropping sulfuric acid, and refluxing for 1-4 hours, extracting and recrystallizing to obtain the modified crosslinking agent.

9. The method for preparing the antiviral glycyrrhizic acid powder according to claim 8, characterized in that: The mass ratio of the product 1 to diethanolamine in step S2 is 1:(0.65-0.70).

10. The method for preparing the antiviral glycyrrhizic acid powder according to claim 8, characterized in that: The mass ratio of the product 2 to the rosin in the step S3 is 1:(2.8-3.3).